COVID-19 has intensified site access issues, accelerated the need for virtual clinical trials, and driven the urgency for remote patient participation and trial monitoring.
How urgent is it for you to support remote patient engagement, informed consent, and data capture using virtualization technologies?
Virtualization requirements are complex and constantly evolving as study teams adapt to ongoing disruptions such as subjects missing hospital visits, sites closing or being overwhelmed with COVID-19 patients, or interruptions to the clinical supply chain.
